Evidence map›Paper›PMID 42239169›Full record

ArticlebioRxiv : the preprint server for biology2026

Evaluating open LLMs for agentic analysis orchestration in a typical biomedical lab.

Anton Nekrutenko

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Anton NekrutenkoDepartment of Biochemistry and Molecular Biology Penn State University, University Park, PA 16802.ORCID 0000-0002-5987-8032

Funding

Implementing the Genomic Data Science Analysis, Visualization, and Informatics Lab-space (AnVIL)U24HG010263 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI Enis Afgan, VINCENT JAMES CAREY · 2018 to 2026
$23.8M
An in integrated platform for multiomic analyses of pathogen and host data using scalable public infrastructureU24AI183870 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI Kelsey M Beavers, Maximilian Haeussler · 2024 to 2026
$10.2M
Democratization of Data Analysis in Life Sciences Through GalaxyU24HG006620 · NHGRI · PENNSYLVANIA STATE UNIVERSITY, THE · PI Daniel James Blankenberg, Jeremy Goecks · 2021 to 2026
$9.8M
The CFDE Cloud WorkspaceOT2OD037936 · OD · UNIVERSITY OF TEXAS AT AUSTIN · PI James Paul Carson, ANTON NEKRUTENKO · 2024 to 2026
$4.9M
Hypothesis Testing using Phylogenies for the 21st century (equipment supplement)R01GM151683 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI Spencer V. Muse, ANTON NEKRUTENKO · 2024 to 2026
$1.2M
NHGRI NIH HHS U24 HG006620NHGRI NIH HHS U24 HG010263NIAID NIH HHS U24 AI183870NIGMS NIH HHS R01 GM151683NIH HHS OT2 OD037936
6 · The paper itself

Abstract

Agentic tools - software environments where a large language model plans, calls external tools, executes code, and iterates with minimal human intervention - will run a substantial share of routine biomedical data analysis within the next few years. However, per-call inference cost on frontier models is the bottleneck and can add up quickly. Here, we tested whether a free, locally-runnable open-weight model could take over the repetitive execution steps at frontier accuracy. We used Claude's Opus to author plans of increasing detail for per-sample variant calling, and ran six 2026-release open-weight implementer LLMs against those plans on a set of desktop GPUs. qwen3.6:27b reproduced frontier accuracy on every plan and matched Opus cell-for-cell on a 36-cell error-injection matrix. A sub-$2,000 Jetson or Apple Mac Mini sufficed for the implementer side. The open-weight model landscape evolves on the order of months, so the specific implementer recommended here will be superseded; we provide the plans, harness, scoring code, and per-cell artifacts at https://github.com/nekrut/LLM-eval-paper as a framework for re-evaluating future models.

Identifiers

PMID42239169
PMCPMC13228249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.